Page last updated: 2024-11-06

2-nitrobenzofuran

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-nitrobenzofuran is a heterocyclic aromatic compound that has been studied for its potential use in organic synthesis and medicinal chemistry. It is typically synthesized via nitration of benzofuran. Research on 2-nitrobenzofuran has explored its reactivity in various reactions, such as nucleophilic aromatic substitution and reduction. It is also a precursor to other heterocyclic compounds with potential biological activity. Its importance lies in its potential to serve as a building block for the development of new drugs and materials. Research efforts aim to understand its chemical properties, synthetic pathways, and potential applications.'

Cross-References

ID SourceID
PubMed CID36328
CHEMBL ID7438
SCHEMBL ID847484
MeSH IDM0110766

Synonyms (21)

Synonym
nsc-170697
nsc170697
33094-66-5
r 5144
2-nitrobenzofuran
brn 0136254
nsc 170697
benzofuran, 2-nitro-
2-nitro-1-benzofuran
2-nitro-benzofuran
CHEMBL7438
AKOS006271665
4-17-00-00481 (beilstein handbook reference)
SCHEMBL847484
nitrobenzofuran
2-nitrobenzo[b]furan
DTXSID80186750
A875431
17-hydroxypregn-4-ene-3,20-dione17-heptanoate
AS-75753
CS-0156003
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1139413Antibacterial activity against replicating form of Mycobacterium tuberculosis MC2 6220 assessed as growth inhibition after 7 days by high-throughput screening assay2014Journal of medicinal chemistry, May-08, Volume: 57, Issue:9
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
AID201368Mutagenicity in Salmonella Typhimurium TA98 was determined1993Journal of medicinal chemistry, Apr-16, Volume: 36, Issue:8
Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis.
AID70453Genotoxicity (SOSIP) on Escherichia coli PQ37 (SOS induction potential data, as a measure of genotoxicity)1993Journal of medicinal chemistry, Apr-16, Volume: 36, Issue:8
Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis.
AID1139416Selectivity index, ratio of LD50 for human HepG2 cells to MIC90 for replicating form of Mycobacterium tuberculosis mc'2 62202014Journal of medicinal chemistry, May-08, Volume: 57, Issue:9
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
AID201366Mutagenicity in Salmonella Typhimurium TA100 was determined1993Journal of medicinal chemistry, Apr-16, Volume: 36, Issue:8
Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis.
AID1139414Antibacterial activity against non-replicating form of Mycobacterium tuberculosis MC2 6220 assessed as growth inhibition after 3 days by high-throughput screening assay2014Journal of medicinal chemistry, May-08, Volume: 57, Issue:9
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
AID23231Calculated partition coefficient (clogP)1993Journal of medicinal chemistry, Apr-16, Volume: 36, Issue:8
Mechanistic interpretation of the genotoxicity of nitrofurans (antibacterial agents) using quantitative structure-activity relationships and comparative molecular field analysis.
AID1139415Cytotoxicity against human HepG2 cells assessed as decrease in ATP signal after 2 days by CellTiter-Glo assay2014Journal of medicinal chemistry, May-08, Volume: 57, Issue:9
Synthetic calanolides with bactericidal activity against replicating and nonreplicating Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's2 (18.18)18.2507
2000's0 (0.00)29.6817
2010's3 (27.27)24.3611
2020's4 (36.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.27

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.27 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.76 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.27)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]